Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 16Terminated 4Recruiting 3Unknown 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Lymphocele 1

Interventions

Docetaxel 21Radiosurgery 19Radiotherapy 17Androgen Antagonists 14Leuprolide 11Goserelin 11bicalutamide 9enzalutamide 8Surveys and Questionnaires 8Prednisone 8Brachytherapy 8Blood Specimen Collection 8Abiraterone Acetate 8acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 7Radiotherapy, Intensity-Modulated 7Multiparametric Magnetic Resonance Imaging 7Gonadotropin-Releasing Hormone 7Triptorelin Pamoate 6pembrolizumab 4cabazitaxel 4abiraterone 4Standard of Care 4Positron Emission Tomography Computed Tomography 4Metformin 4Heavy Ion Radiotherapy 4Exercise 4Estramustine 4luprolide acetate gel depot 3darolutamide 3Watchful Waiting 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Prostatic Neoplasms × Prostatectomy × Clear all
NCT06258486 2024-02-26

Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks

Kaiser Permanente

Phase 4 Unknown
100 enrolled
Genitourinary

Lymphocele, Prostatic Neoplasms

NCT03541928 2021-04-06

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

The Methodist Hospital Research Institute

Phase 2 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡